Should patients with mild asthma be excluded from allergic rhinitis drug trials?

Anne Marie Salapatek (Mississauga, Canada), Anne Marie Salapatek, Peter Couroux, Victoria Nelson, Piyush Patel

Source: International Congress 2015 – Immune mechanisms in the human lung
Session: Immune mechanisms in the human lung
Session type: Thematic Poster Session
Number: 4026
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anne Marie Salapatek (Mississauga, Canada), Anne Marie Salapatek, Peter Couroux, Victoria Nelson, Piyush Patel. Should patients with mild asthma be excluded from allergic rhinitis drug trials?. Eur Respir J 2015; 46: Suppl. 59, 4026

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

Comparative efficacy of different groups of drugs for the treatment of bronchial asthma in combination with allergic rhinitis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Treatment and outcomes in patients with asthma and allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

APEXII- A prospective study investigating the efficacy of omalizumab treatment in severe allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015


First clinical trial of a new IgE-adsorber in allergic asthma
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015

QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014


Risk factors of incomplete asthma control in asthmatic patients with allergic rhinitis
Source: Annual Congress 2013 –Asthma
Year: 2013


Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone
Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Year: 2007


Allergic rhinitis and coexistence of allergic rhinitis and asthma at Greek children. Comparison of clinical and laboratory pararameters
Source: Eur Respir J 2006; 28: Suppl. 50, 255s
Year: 2006

Evaluation of asthma patients using the control of allergic rhinitis and asthma test (CARAT)
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012


Asthma among allergic rhinitis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 108s
Year: 2003

Allergy markers in relation to allergic rhinitis and asthma in relatives of asthmatics in the EGEA study
Source: Eur Respir J 2003; 22: Suppl. 45, 115s
Year: 2003

The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta
Source: International Congress 2016 – Asthma management
Year: 2016


Long-term using of omalizumab in children with atopic severe persistent non-controlled asthma
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013

Allergic rhinitis and asthma: combined syndrome, unified treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003

Persistent allergic sensitization is associated with asthma and rhinitis among adults
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016

Anti-IgE: lessons from clinical trials in patients with severe allergic asthma symptomatic despite optimised therapy
Source: Eur Respir Rev 2007; 16: 73-77
Year: 2007



The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001